IBD & Intestinal Disorders
Conference Coverage
AI-Identified Vascular Healing Can Predict Clinical Relapse in Ulcerative Colitis
Image-enhanced endoscopy is spreading in routine practice as a way to detect inflammation and to predict outcomes.
Conference Coverage
Novel Biotherapeutic to Be Tested in Ulcerative Colitis
The eight-strain live biotherapeutic product is due to enter its first clinical trial later this year.
Conference Coverage
Risankizumab in Crohn’s Disease: Clinical, Endoscopic Outcomes Remain Stable for up to 3 Years
The ongoing study is evaluating the long-term efficacy and safety of risankizumab in patients with moderate to severe CD.
Conference Coverage
Capsule Endoscopy–Guided Treatment Reduces Flares in Crohn’s Disease Compared With Standard Care
Despite the results, there remains a dilemma about who should be treated if they show mucosal inflammation on video capsule endoscopy.
From the AGA Journals
No-Biopsy Approach to Celiac Disease Diagnosis Appears Effective for Select Adult Patients
The no-biopsy approach remains controversial for diagnosing adult patients.
From the Journals
Mood Interventions May Reduce IBD Inflammation
Psychological therapies had the best outcomes related to IBD inflammation, compared with antidepressants or exercise.
Conference Coverage
Biosimilars Have Driven Down Cost of Infliximab
Two studies show significant cost declines, but it remains unclear if patients see savings or access to the agents has improved.
Conference Coverage
In Refractory IBD, Combination Therapies Appear Safe, Effective
Updated meta-analysis names combination with highest response and remission rates and fewest adverse events.
From the AGA Journals
Telephone Best for Switching Patients to New Colonoscopy Intervals
Telephone outreach may be a reasonable approach to update patients on post-polypectomy surveillance guideline changes if secure messaging or text...
The New Gastroenterologist
Working together
Welcome to the February issue of The New Gastroenterologist.